Shilajit and Corticosteroids (Prednisolone, Dexamethasone, Hydrocortisone)

Shilajit is a natural resin rich in minerals and humic substances that has been used in Ayurveda for centuries. Modern analyses indicate that it consists mainly of humic acids (including fulvic acids) and minerals; the exact composition varies depending on origin and processing. (5)

Corticosteroids such as prednisolone, dexamethasone and hydrocortisone are potent anti-inflammatory medicines that act via the body’s own cortisol system – the hypothalamic–pituitary–adrenal (HPA) axis. A central question is whether Shilajit, which is often described as having adaptogenic properties, may influence the HPA axis and thereby potentially affect the action or side effects of corticosteroids. This possible interaction is outlined below with reference to current evidence. For an overview of Shilajit itself, you can also read our article on the effects of Shilajit.

Mechanism of the possible interaction

Corticosteroids suppress the HPA axis via negative feedback and, with longer-term use at higher doses, may lead to reduced adrenal function. This is described in detail in current clinical guidelines. (2)

Shilajit contains, among other components, fulvic acids and dibenzo-α-pyrones. Animal data suggest that Shilajit may modulate the HPA axis under stress: in a rat model, stress-related changes in corticosterone levels and adrenal parameters were normalised. (1)

In a placebo-controlled human study, Shilajit (250 mg, twice daily for 90 days) was associated with increases in total and free testosterone and DHEA-S – an adrenal androgen – in healthy men. A direct effect on cortisol was not assessed in this study. (3)

From a pharmacokinetic perspective, many systemic corticosteroids (e.g. prednisolone) are metabolised via CYP3A4. For Shilajit itself there are currently no robust data on inhibition/induction of CYP3A4 or P-glycoprotein; any specific pharmacokinetic interactions therefore remain speculative at this time. (6)

Clinical evidence

Direct studies on Shilajit and corticosteroids are, to current knowledge, not available. The existing data are indirect:

• Animal model: Shilajit was associated with normalisation of stress markers of the HPA axis and mitochondrial parameters. (1)
• Human study: Increases in testosterone and DHEA-S after 90 days of Shilajit; cortisol was not measured. (3)
• Glucocorticoids: Guidelines document dose- and duration-dependent HPA suppression and emphasise cautious tapering and monitoring. (2)
• Even local steroids can – rarely – affect the HPA axis, underlining the sensitivity of this system. (4)

In summary: there is a theoretical interaction through their shared impact on the HPA axis, but no clinical data demonstrating a relevant enhancement or reduction of corticosteroid effects by Shilajit.

Shilajit Capsules

✓ High-quality, natural Shilajit from the Himalayas

✓ With 50% fulvic acid & 12% humic acid

✓ 500 mg Shilajit extract per capsule

✓ Extract ratio 50:1 (equivalent to 25,000 mg Shilajit resin per capsule)

£18.00

ADD TO BASKET

View product

Risk assessment

Product quality is another factor: the composition of Shilajit varies considerably; analyses describe high proportions of humic substances but also trace elements/heavy metals, sometimes within and sometimes above recommended limits. (5)

Conclusion: clinically relevant interactions have not been demonstrated, but due to the involvement of the HPA axis, caution may be advisable during sensitive phases (e.g. tapering).

Practical recommendations

1. Discuss with a doctor: Before starting Shilajit while using systemic steroids, always seek medical advice – especially with dexamethasone (long duration of action) and when tapering is planned. (2)
2. Timing: If your doctor sees no contraindication, do not start Shilajit at the same time as steroid tapering. Consider starting only once the maintenance dose is stable and the clinical situation is unremarkable.
3. Laboratory tests: If endocrine testing is planned (e.g. morning cortisol, function tests), consider pausing Shilajit beforehand to minimise potential influencing factors. (2)
4. Monitoring: Watch for signs that could indicate reduced adrenal function during tapering (tiredness, dizziness, nausea, drop in blood pressure) and for typical steroid-related side effects (blood sugar, blood pressure, susceptibility to infections). (2)
5. Quality & safety: Use only purified Shilajit products with an analysis certificate (heavy metals/microbiology). (5)
6. Spacing from medicines: Even without proven pharmacokinetic interactions, a time interval of around 2 hours between Shilajit and medicines is commonly used in practice to reduce potential absorption issues.
7. Consider alternatives: For stress management, prioritise evidence-based approaches (sleep, physical activity, psychological methods); supplements should be reviewed by a healthcare professional.

You can find more on potential supplement interactions in our article Shilajit: Interactions and on possible unwanted effects in Shilajit: Side effects.

Conclusion

Shilajit and corticosteroids both act – albeit in different ways – on the HPA axis. While there are well-established guidelines on HPA suppression with steroids, clinical data on Shilajit–steroid interactions are currently not available. The interaction therefore remains theoretically plausible but unproven. Anyone considering Shilajit while taking prednisolone, dexamethasone or hydrocortisone should do so under medical supervision, plan the timing of intake carefully and exercise particular caution during tapering. Further background information can be found in our overview Shilajit: Effects.

Medical disclaimer

Important notice: This information does not replace professional medical advice. Always consult your doctor or pharmacist before taking Shilajit together with corticosteroids (prednisolone, dexamethasone, hydrocortisone). Every person may respond differently to food supplements and medicines.